• When 7-9 September, 2026
  • Where InterContinental Barcelona
  • Search

What's In Store For You? 

With advanced therapies reshaping the future of medicine, pharma leaders are under pressure to integrate cutting-edge science while navigating regulatory and manufacturing complexity. Advanced Therapies Europe brings you face-to-face with the biotech pioneers and solution providers driving change.

Join your peers to accelerate partnerships, de-risk pipelines, and explore next-gen CGT innovations.

✅ 996 pre-arranged meetings.
✅ 171 Therapeutic Developers
✅ Curated 1:1 partnering designed for outcomes.

Apply to attend

CGT is now a strategic priority, but scaling delivery, access, and integration remains a core challenge

For pharma, CGT is no longer exploratory—it’s a strategic pillar. The challenge is integrating complex therapies into existing pipelines while managing manufacturing, access, and pricing at scale. Speed, partnerships, and platform thinking are now critical to staying competitive.

  • Internal capabilities must evolve to support advanced manufacturing and delivery models
  • Partnerships with biotechs are essential to access innovation and share risk
  • Market access and reimbursement complexity are becoming central to portfolio decisions

Discover Advanced Therapies Europe as a pharmaceutical company

Explore how Advanced Therapies Europe empowers biotechs to accelerate their commercialization journey. From engaging with investors at our exclusive Investor Pre-Day to building valuable partnerships with industry leaders, every moment is designed to drive your success. Dive into the agenda, connect with peers, and meet solution providers ready to support your growth.

Content Packed Agenda

Gain insights, meet investors, and accelerate your path to commercialization.

State of the Art Networking

Discover promising companies, network with peers, and explore new opportunities.

Source Cutting-Edge Innovation

Discover high-potential biotech partners aligned with your pipeline and external innovation goals.

De-risk Through Strategic Collaboration

Hear from peers on building value-driven partnerships that balance risk and reward across the CGT lifecycle.

Key themes to discover...

  • Access to innovation - Identify assets and platforms aligned to your strategy. Meet biotechs progressing toward clinical and commercial milestones, ready for meaningful partnership discussions.
  • Building effective partnerships - Engage biotech, manufacturing and service partners in structured meetings designed to move conversations forward quickly and efficiently.
  • Manufacturing and supply readiness - Explore solutions addressing capacity, cost and complexity. Understand how to build resilient supply strategies to support advanced therapies at scale.

  • Navigating pricing and access - Gain insight into payer expectations and market access strategies. Learn how to position therapies for approval and adoption across Europe.
  • Long-term competitiveness - Global competition is intensifying. Connect with leaders shaping the next phase of growth and refine your strategy to act with greater speed and confidence.

View the agenda

Identify Strategic Partnerships That Accelerate Your Pipeline

For pharma leaders seeking external innovation, this is where meaningful partnerships begin. Engage directly with biotechs developing assets aligned to your pipeline and strategic priorities.

The Delegate Pack ensures you can plan engagements with precision.

Inside the delegate pack:

  • A breakdown of biotechs actively seeking licensing, co-development, or acquisition
  • Visibility into therapeutic areas and platform technologies represented
  • How curated 1:1 meetings align with your partnering strategy
  • Agenda insights highlighting trends in collaboration and deal-making

Download the Delegate Pack

Who Might You Find On the Show Floor?

2025 Attendee List 2025 Exhibitor List

600+
Attendees
40+
Companies
90+
Speakers
170+
Therapeutic Developers

 

  • "What an incredible few days at the ATE conference by Phacilitate! Grateful for the power of my network and the opportunity to meet so many familiar faces while growing it further.”
    Head of Business Development: Cell Therapy and Laboratory Services | Cell and Gene Therapy
  • “Impactful moments and connections.”
    Director Global Cell and Gene Therapies Portfolio Management | EMBA | Deep Tech
  • “Already having fantastic conversations here at ATE24 in Lisbon.”
    Experienced Leader in Cell and Gene Therapy Business and Commercial Strategy